Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Calidi Biotherapeutics Announces Presentation at 6th Annual Oncolytic Virotherapy Summit
LA JOLLA, Calif.–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem…
Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy Technology
LA JOLLA, Calif.–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company with novel allogeneic stem cell…
Calidi Biotherapeutics Announces Agreement with Northwestern University for Exclusive Commercial Rights to their IND for Treatment of Malignant Glioma
LA JOLLA, Calif.–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem…
Calidi Biotherapeutics Announces Partnership with GenScript ProBio for Distribution of its SuperNova-1 Technology
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces European Patent Granted by EPO: Combination Immunotherapy Approach for Treatment of Cancer
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces FDA Approval for COVID-19 Treatment Manufactured by Partner, Personalized Stem Cells
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…